-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the State Drug Administration approved the registration
of the innovative product "Umimos Coated Coronary Balloon Expansion Catheter" produced by Shandong Jiwei Medical Products Co.
, Ltd.
after review.
The Melimos-coated coronary balloon dilation catheter consists of a balloon dilation catheter and a drug coating on the balloon, and the balloon catheter is composed of
a balloon, distal tube, transition tube and proximal canal.
The drug coating contains melilimus and polyethylene oxide carriers at a dose of 3 μg/mm2
.
The product is sterilized by ethylene oxide and used for single use
.
The product adheres to the balloon surface by a polyethylene oxide carrier, and the hydrophilic properties of polyethylene oxide and the lipophilic properties of melismus allow the drug to be released from the balloon surface and quickly enter the blood vessel wall
.
As an endovascular drug release technology, the drug balloon can release effective therapeutic concentration drugs at the site of the lesion, solve and treat coronary heart disease intervention and intrastent restenosis lesions
.
The product is suitable for the treatment of primary coronary artery vascular disease with a vascular diameter of 2.
0mm-2.
75mm, providing a new choice
for patients with primary small-vessel disease.
The drug supervision and administration department will strengthen the post-marketing supervision of the product to protect the safety
of patient equipment.
Recently, the State Drug Administration approved the registration